Will challenge NGT order to close down Gujarat plant: JB Chemicals

JB Chemicals said that it has been operating the plant with a valid environmental clearance

Specialty chemicals maker Dorf Ketal acquires Filtra Catalysts
Press Trust of India New Delhi
Last Updated : Jan 13 2016 | 3:28 PM IST
JB Chemicals & Pharmaceuticals today said it will challenge in the Supreme Court an order by the National Green Tribunal (NGT) which has directed closure of its bulk drugs plant at Panoli, Gujarat within a month.

In a regulatory filing, JB Chemicals & Pharmaceuticals said the NGT (West Zone) has via order dated January 8, 2016 termed the environmental clearance given to it by the Centre as "illegal" and "directed the Government of India to revoke within one month the environment clearance granted to the company's plant".

Consequently, the NGT has also "directed the company to close down the activities at the said plant within four weeks", it added.

JB Chemicals, however, said it has been operating the plant with a valid environmental clearance which was accorded to the plant by the Ministry of Environment and Forest in January 1994.

"The company plans to immediately appeal the said order in the Supreme Court and is confident that the Court will grant relief to the company especially in light of various technical and factual aspects involved in the matter," it said.

The NGT order has come after the Paryavartan Suraksha Samiti, Vododara and Peoples Union for Civil Liberties, Ankleshwar challenged the said environment clearance to the manufacturing facility.

During 2014-15, the total sale of bulk drugs manufactured at the said plant amounted to Rs 104 crore. Besides, the company also uses active pharmaceutical ingredients (APIs) produced at this plant for captive consumption.

JB Chemicals & Pharmaceuticals' stock was trading at Rs 263.55, down 3.66 per cent, on the BSE.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 13 2016 | 3:13 PM IST

Next Story